Novartis Ag Stock Analysis

Novartis Pink Sheet Analysis Notes

About 34.0% of the company shares are owned by institutional investors. The book value of Novartis was now reported as 28.0. The company last dividend was issued on the 9th of March 2023. Novartis AG had 40:1 split on the 7th of May 2001. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 104323 people.The quote for Novartis AG is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Novartis AG contact the company at 41 61 324 1111 or learn more at https://www.novartis.com.

Novartis Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 183.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novartis's market, we take the total number of its shares issued and multiply it by Novartis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novartis Profitablity

The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.

Technical Drivers

As of the 22nd of July, Novartis secures the Downside Deviation of 2.38, mean deviation of 1.04, and Risk Adjusted Performance of 0.1172. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG, as well as the relationship between them. Please verify Novartis AG jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Novartis AG is priced some-what accurately, providing market reflects its recent price of 118.7 per share. Given that Novartis AG has jensen alpha of 0.1582, we recommend you to check Novartis's last-minute market performance to make sure the company can sustain itself at a future point.

Novartis AG Price Movement Analysis

Novartis Outstanding Bonds

Novartis Predictive Daily Indicators

Novartis Forecast Models

Novartis' time-series forecasting models are one of many Novartis' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novartis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Novartis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novartis shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Novartis. By using and applying Novartis Pink Sheet analysis, traders can create a robust methodology for identifying Novartis entry and exit points for their positions.

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.